Blood pressure, hematologic and erythrocyte fragility changes in children suffering from sickle cell anemia following ascorbic acid supplementation.

Jaja, S I; Ikotun, A R; Gbenebitse, S; Temiye, E O

Jaja, S I; Ikotun, A R; Gbenebitse, S; Temiye, E O.

Affiliation

Jaja SI; Department of Physiology, College of Medicine, University of Lagos, Nigeria. sjaja4@yahoo.com

J Trop Pediatr ; 48(6): 366-70, 2002 12.

Article in En | MEDLINE | ID: mdl-12521281

Subject(s)

Anemia, Sickle Cell/drug therapy; Ascorbic Acid/therapeutic use; Anemia, Sickle Cell/blood; Anemia, Sickle Cell/physiopathology; Blood Pressure/drug effects; Child; Child, Preschool; Data Interpretation, Statistical; Erythrocytes, Abnormal/drug effects; Female; Fetal Hemoglobin/drug effects; Hematocrit; Humans; Male; Nigeria; Osmotic Fragility/drug effects

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ascorbic Acid / Anemia, Sickle Cell Limits: Child / Child, preschool / Female / Humans / Male Country/Region as subject: Africa Language: En Journal: J Trop Pediatr Year: 2002 Document type: Article Affiliation country: Nigeria Country of publication: United kingdom

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google